Volume 87 Issue 28 | pp. 16-17 | Concentrates
Issue Date: July 13, 2009

EC To Intensify Pharma Scrutiny

Department: Business
Keywords: European Commission, generic drugs, antitrust

The European Commission says it will intensify its scrutiny of anticompetitive practices in the pharmaceutical industry, particularly practices that hinder the introduction of low-cost generic drugs. An inquiry launched by the administrative arm of the European Union more than a year ago (C&EN Online Latest News, Jan. 17, 2008) turned up significant delays in the introduction of generics after original makers' patents expired. Neelie Kroes, commissioner for competition policy, says that the first . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society